Techno Medica Co., Ltd. (JP:6678) has released an update.
Techno Medica Co., Ltd. reported a strong financial performance for the quarter ending June 30, 2024, with net sales up by 12.9% and operating profit surging by 207.2% from the previous year. The company’s total assets decreased slightly from the previous quarter, while maintaining a high equity-to-asset ratio of 84.4%. Despite the robust results, Techno Medica did not prepare supplementary material or hold a financial results briefing, and kept the cash dividend forecast unchanged.
For further insights into JP:6678 stock, check out TipRanks’ Stock Analysis page.
